Integration of peripheral blood biomarkers with computed tomography to differentiate benign from malignant pulmonary opacities.

Cancer detection and prevention

Volumn 25, Issue 4, 2001, Pages 336-343

  Aloia, T ^a   Bepler, G ^a   Harpole, D ^a   Goodman, P C ^a   McAdams, H P ^a   Erasmus, J J ^a   Herndon, J E ^a   Patz Jr , E F ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CA 15-3 ANTIGEN; KERATIN; MESSENGER RNA; PEPTIDE FRAGMENT; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; FEMALE; GENETICS; HUMAN; LUNG DISEASE; LUNG TUMOR; MALE; METHODOLOGY; MIDDLE AGED; PILOT STUDY; RADIOGRAPHY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; AGED, 80 AND OVER; CA-15-3 ANTIGEN; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; KERATINS; LUNG DISEASES; LUNG NEOPLASMS; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PILOT PROJECTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TOMOGRAPHY, X-RAY COMPUTED; TUMOR MARKERS, BIOLOGICAL;

EID: 0035230029     PISSN: 0361090X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)